Characterisation of a Xp21 microdeletion syndrome in a 2-year-old boy with muscular dystrophy, glycerol kinase deficiency and adrenal hypoplasia congenita

1991 ◽  
Vol 86 (4) ◽  
Author(s):  
M. Stuhrmann ◽  
H. Heilbronner ◽  
A. Reis ◽  
R.-D. Wegner ◽  
P. Fischer ◽  
...  
Keyword(s):  
Muscular Dystrophy ◽  
Glycerol Kinase ◽  
Microdeletion Syndrome ◽  
Adrenal Hypoplasia Congenita ◽  
Glycerol Kinase Deficiency ◽  
Adrenal Hypoplasia

Glycerol kinase deficiency and adrenal hypoplasia congenita

1997 ◽  
Vol 20 (4) ◽  
pp. 609-609 ◽  
Author(s):  
R. A. Clarke ◽  
N. Howard ◽  
W. J. O'Sullivan ◽  
L. G. Svirklys ◽  
A. G. Mackinlay
Keyword(s):  
Glycerol Kinase ◽  
Adrenal Hypoplasia Congenita ◽  
Glycerol Kinase Deficiency ◽  
Adrenal Hypoplasia

Deletion proximal to DXS68 locus (L1 probe site) in a boy with Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal hypoplasia

1988 ◽  
Vol 78 (3) ◽  
pp. 222-227 ◽  
Author(s):  
J. Chelly ◽  
F. Marlhens ◽  
B. Dutrillaux ◽  
G. J. Van Ommen ◽  
M. Lambert ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Glycerol Kinase ◽  
Glycerol Kinase Deficiency ◽  
Probe Site ◽  
Adrenal Hypoplasia

scholarly journals A YAC contig in Xp21 containing the adrenal hypoplasia congenita and glycerol kinase deficiency genes

1992 ◽  
Vol 1 (8) ◽  
pp. 579-585 ◽  
Author(s):  
Ann P. Walker ◽  
Jamel Chelly ◽  
Donald R. Love ◽  
Yumiko Ishikawa Brush ◽  
Dominique Récan ◽  
...  
Keyword(s):  
Glycerol Kinase ◽  
Adrenal Hypoplasia Congenita ◽  
Glycerol Kinase Deficiency ◽  
Adrenal Hypoplasia ◽  
Yac Contig

Congenital adrenal hypoplasia, Duchenne muscular dystrophy, and glycerol kinase deficiency: importance of laboratory investigations in delineating a contiguous gene deletion syndrome

1994 ◽  
Vol 40 (11) ◽  
pp. 2099-2103 ◽  
Author(s):  
D E Cole ◽  
L A Clarke ◽  
D C Riddell ◽  
K A Samson ◽  
W K Seltzer ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Gene Deletion ◽  
Glycerol Kinase ◽  
Deletion Syndrome ◽  
Congenital Adrenal Hypoplasia ◽  
Contiguous Gene ◽  
Glycerol Kinase Deficiency ◽  
Adrenal Hypoplasia ◽  
Contiguous Gene Deletion Syndrome

Abstract We describe an infant with adrenal insufficiency who was subsequently diagnosed with Duchenne muscular dystrophy (DMD) and hyperglycerolemia due to glycerol kinase deficiency. Karyotyping showed a deletion on the short arm of the X chromosome (p21.1 to p22.1). Molecular mapping revealed that the deletion extended from the 3' end of the DMD gene to a site telomeric to the loci for X-linked congenital adrenal hypoplasia and glycerol kinase deficiency. These results are diagnostic for an Xp21 contiguous gene deletion syndrome--so named because the deletion manifests as a distinctive cluster of otherwise unrelated single-gene disorders in the same individual. The Xp21 syndrome should be considered in any infant with adrenal insufficiency. Measurement of serum triglycerides (without glycerol blanking) and creatine kinase activity are simple screening tests that may facilitate early diagnosis and appropriate genetic counseling about risks of recurrence in subsequent offspring.

scholarly journals A rare co-occurrence of duchenne muscular dystrophy, congenital adrenal hypoplasia and glycerol kinase deficiency due to Xp21 contiguous gene deletion syndrome: case report

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Asanka Rathnasiri ◽  
Udara Senarathne ◽  
Visvalingam Arunath ◽  
Thabitha Hoole ◽  
Ishara Kumarasiri ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Gene Deletion ◽  
Glycerol Kinase ◽  
Deletion Syndrome ◽  
Congenital Adrenal Hypoplasia ◽  
Contiguous Gene ◽  
Glycerol Kinase Deficiency ◽  
Adrenal Hypoplasia ◽  
Contiguous Gene Deletion Syndrome

Abstract Background Contiguous gene deletion syndromes are rare genomic disorders caused by deletion of large segments of DNA resulting in co-occurrence of apparently unrelated multiple clinical phenotypes. We report a boy with contiguous gene deletion involving Xp21 genomic location. Case presentation A Sri Lankan boy with developmental delay and failure to thrive first presented at three years of age with hypovolaemia, hyperpigmentation and drowsiness. Investigations done at that time revealed hypoglycaemia, hyponatraemia, hyperkalaemia, low cortisol, low aldosterone, high ACTH and low 17-hydroxyprogesterone. He was diagnosed to have primary adrenal insufficiency. During follow-up at five years, he was noted to have progressive difficulty in walking, waddling gait, hypotonia, calf hypertrophy and positive Gower’s sign. His creatine kinase was very high, and the electromyogram showed myopathy. Genetic analysis revealed hemizygous deletion involving the final 35 exons of the dystrophin gene confirming the diagnosis of Duchenne muscular dystrophy. Further investigations revealed pseudohypertriglyceridemia, large glycerol peak on urine organic acid analysis and hemizygous deletion of the glycerol kinase gene confirming glycerol kinase deficiency. Based on the presence of Duchenne muscular dystrophy, glycerol kinase deficiency and probable congenital adrenal hypoplasia along with genetic confirmation of deletions involving dystrophin and glycerol kinase genes, the diagnosis of Xp21 contiguous gene deletion syndrome was made. Conclusions We report a child with contiguous gene deletion syndrome who was initially diagnosed as having isolated primary adrenal insufficiency probably due to congenital adrenal hypoplasia. Later he was confirmed to have Duchenne muscular dystrophy and glycerol kinase deficiency, as well. This case report highlights the importance of pre-emptive evaluation and identification of genetic defects when patients present with seemingly unrelated diseases that could aid in accurate diagnoses of contiguous gene deletion syndromes.

Sign in / Sign up

Export Citation Format

Share Document